Key result
Lipoprotein lipase gene variants are linked to metabolic syndrome, CAD, and stroke.
Why the study?
LPL activity can be affected by genetic alterations that alter lipid metabolism, warranting an examination of recent studies on the role of LPL gene variants in metabolic syndrome and cardiovascular diseases.
This review highlights the pathophysiological role of lipoprotein lipase (LPL) gene variants in the development of metabolic syndrome and cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
LPL variant associations with MetS and CVD should not change practice; leaves open causal validation and therapeutic relevance.
Lipoprotein lipase (LPL) is a glycoprotein that is produced and secreted into the interstitial space in various tissues, including the cardiac muscle, adipose tissue, macrophages, and skeletal muscle. LPL activity could be affected by genetic alterations which result in changes in lipid metabolism. This review article only focuses on reporting the recent studies which mainly explain the role of the LPL gene variants in metabolic syndrome and cardiovascular diseases. There are over 100 LPL gene variants, but this review article reported rs1801177, rs118204069, rs118204057, rs118204060, rs118204068, rs268, and rs328 as the most common in metabolic syndrome patients. In cardiovascular diseases, LPL variants rs1801177, rs268 and rs328 were the most prevalent. Therefore, it is suggested that further studies should be conducted to identify the LPL gene variants in other cardiovascular diseases, including cardiac arrhythmia. This review article concludes that LPL deficiency and dysfunction are associated with many diseases, such as obesity, insulin resistance, diabetes, chylomicronemia, atherosclerosis, myocardial infarction, coronary artery disease, and stroke.
No takes yet. Share an insight, caveat, or question.
Rafaqat et al. (2024) conducted a review in Metabolic disorders and cardiovascular diseases. Lipoprotein lipase (LPL) variants was evaluated. Lipoprotein lipase gene variants, particularly rs1801177, rs268, and rs328, are associated with metabolic syndrome and cardiovascular diseases such as coronary artery disease and stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: